Novartis
Novartis is a global healthcare company based in Basel, Switzerland that provides healthcare solutions to address the evolving needs of patients and societies worldwide. Our broad portfolio includes innovative pharmaceuticals and oncology medicines, generic and biosimilar medicines and eye care devices. Our mission is to discover new ways to improve and extend people’s lives. Our vision is to be a trusted leader in changing the practice of medicine. Our strategy is to use science-based innovation to deliver better outcomes for patients in growing areas of healthcare.
RELATED ARTICLES
Researcher Profile: Craig Mickanin
A biopharmaceutical researcher at Novartis, Craig has spent most of his two-decade career studying cell and gene therapies.
Researcher Profile: Rebecca Leary
Rebecca Leary works at the forefront of precision medicine, pursuing technologies that characterize cancer cells and their relationship with the body's own immune system.
Getting Ahead of Migraines
Understanding migraines fully can give patients back time taken by the disease.
Researcher Profile: Jennifer Allport-Anderson
Dr. Allport-Anderson works to find new medicine for cardiovascular metabolic diseases, which can lead to health problems such as heart attacks and diabetes.
Researcher Profile: Tom Marsilje
It was supposed to be one of the best days of Tom Marsilje's life. After years of hard work and determination, the research team he was a member of had developed a new drug to treat lung cancer.
A New Era in Personalized Medicine for Cancer Patients
How genetically altering and boosting special immune cells of patients suffering from certain forms of cancer may eliminate disease.
POPULAR ARTICLES
HIV/AIDS: From An Acute Fatal Disease to A Chronic, Manageable Condition
<p>The evolution of HIV/AIDS treatment is nothing short of remarkable. In the 1980s, HIV/AIDS was an acute fatal disease. Today it is a chronic, manageable condition thanks to the commitment of biopharmaceutical researchers, health care workers and advocates.</p>
READ MORE
Combatting Sickle Cell Disease with Cell & Gene Therapy
<p><span><span><span><a><span lang="EN"><span>America's biopharmaceutical companies are researching and developing new treatments to alleviate the tremendous burden of this devastating and painful disease and to improve the quality of life for sickle cell patients.</span></span></a></span></span></span></p>
READ MORE
Why Has Research into Alzheimer's Disease Been So Hard?
<p>Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?</p>
READ MORE
5 Recent Developments Advancing Vaccines
As communities continue to grapple with the impact of COVID-19, vaccines have once again come to the forefront as a critical health care tool.
READ MORE
The Innovation Ecosystem Fuels Breakthroughs
Biopharmaceutical research companies are uniquely positioned to take the necessary risks to further advance research into safe and effective treatments for patients.
READ MORE
Understanding mRNA Vaccines
Scientists at Pfizer are breaking barriers with mRNA technology, one of the approaches used to develop COVID-19 vaccines.
READ MORE
Protecting Alzheimer's Research
15 million people will live with Alzheimer's by 2060. We're working to change that.
READ MORE